Prolonged GPx-1 activation in animal models may disrupt insulin signaling pathways (40, 41), and GPx-1 overexpression has been associated with obesity and insulin resistance in experimental settings (42), whereas its reduction tends to mitigate these effects (43). This evidence concerns the gene INS and Insulin resistance.